-
Posted by
Two Blokes Jun 25 -
Filed in
Stock
-
2 views
SAN FRANCISCO , June 25, 2025 /PRNewswire/ -- On June 23, 2025 investors in Hims & Hers Health, Inc. (NYSE: HIMS) saw the price of their shares crash over 30% after Novo Nordisk announced that it terminated its collaboration with the telehealth company due to concerns about Hims & Hers' sales and "deceptive" marketing of the weight loss drug Wegovy\u00ae. This news has prompted national shareholders rights firm Hagens Berman to open an investigation into possible violations of the securities laws.
